| NASDAQ (usa) |
|
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
![]() |
7487.96 | -5.12 | -0.07% |
| DAX (german) |
|
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
ANGLE plc (LSE: AGL)
AGL Technical Analysis
5
| As on 28th Oct 2025 AGL STOCK Price closed @ 2.40 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 8.06 & Strong Sell for SHORT-TERM with Stoploss of 11.98 we also expect STOCK to react on Following IMPORTANT LEVELS. |
AGLSTOCK Price
| Open | 2.65 | Change | Price | % |
| High | 2.90 | 1 Day | -0.25 | -9.43 |
| Low | 2.33 | 1 Week | 0.55 | 29.73 |
| Close | 2.40 | 1 Month | -0.85 | -26.15 |
| Volume | 1497072 | 1 Year | -7.60 | -76.00 |
| 52 Week High 16.50 | 52 Week Low 1.75 | ||||
LSE UK Most Active Stocks
| ALBA | 0.01 | 0.00% |
| UKOG | 0.01 | 0.00% |
| MSMN | 0.02 | 0.00% |
| ENET | 0.01 | 0.00% |
| ROCK | 0.14 | -12.50% |
| DEMG | 0.02 | -50.00% |
| TRP | 0.03 | 0.00% |
| MIRI | 0.01 | 0.00% |
| SMDS | 582.50 | 0.00% |
| DKE | 0.15 | 0.00% |
LSE UK Top Gainers Stocks
LSE UK Top Losers Stocks
| AGL Daily Charts |
AGL Intraday Charts |
Whats New @ Bazaartrend |
AGL Free Analysis |
|
|
AGL Important Levels Intraday
| RESISTANCE | 3.50 |
| RESISTANCE | 3.15 |
| RESISTANCE | 2.93 |
| RESISTANCE | 2.71 |
| SUPPORT | 2.09 |
| SUPPORT | 1.87 |
| SUPPORT | 1.65 |
| SUPPORT | 1.30 |
AGL Forecast December 2025
| 4th UP Forecast | 18.01 |
| 3rd UP Forecast | 13 |
| 2nd UP Forecast | 9.91 |
| 1st UP Forecast | 6.81 |
| 1st DOWN Forecast | -2.01 |
| 2nd DOWN Forecast | -5.11 |
| 3rd DOWN Forecast | -8.2 |
| 4th DOWN Forecast | -13.21 |
AGL Weekly Forecast
| 4th UP Forecast | 7.22 |
| 3rd UP Forecast | 5.67 |
| 2nd UP Forecast | 4.72 |
| 1st UP Forecast | 3.76 |
| 1st DOWN Forecast | 1.04 |
| 2nd DOWN Forecast | 0.08 |
| 3rd DOWN Forecast | -0.87 |
| 4th DOWN Forecast | -2.42 |
AGL Forecast2025
| 4th UP Forecast | 33.14 |
| 3rd UP Forecast | 23.28 |
| 2nd UP Forecast | 17.19 |
| 1st UP Forecast | 11.09 |
| 1st DOWN Forecast | -6.29 |
| 2nd DOWN Forecast | -12.39 |
| 3rd DOWN Forecast | -18.48 |
| 4th DOWN Forecast | -28.34 |
ANGLE plc ( LSE UK Symbol : AGL )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
AGL Other Details
| Segment | EQ | |
| Market Capital | 279561920.00 | |
| Sector | Healthcare | |
| Industry | Diagnostics & Research | |
| Offical website | > echo $website ; ?> | |
AGL Address
![]() |
||
AGL Latest News
AGL Business Profile
ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products worldwide. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in cancer patient blood; and HyCEAD multiplex analysis system used as the downstream analysis tool in the ovarian cancer clinical application. It also offers specialist circulating tumor cell enrichment and analysis services to support translational research studies and pharmaceutical trials. The company was founded in 1994 and is based in Guildford, the United Kingdom. Address: Surrey Research Park, Guildford, United Kingdom, GU2 7AF
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service

